← Eichor
Study identifier: NCT06112171 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

Condition: Peripheral Arterial Disease  ·  Sponsor: University of Leipzig

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is an investigator-initiated, prospective, single-center, 1:1 randomized pilot study. The trial evaluates the safety and efficacy of intravascular lithotripsy in comparison to standard lesion preparation using standard and/or high-pressure balloon angioplasty in patients with femoropopliteal artery disease. All patients will receive subsequent Supera stent implantation at the operator's discretion. Additional standard nitinol bare metal stent (BMS), drug-eluting stent or covered stent implantation is at the operator's discretion. Patients will be stratified for total occlusions.

This description comes directly from the study's public registry record.

Talk to the study team

Sabine Steiner, Prof. Dr.  ·  +49-341-97  ·  Sabine.Steiner@medizin.uni-leipzig.de

Janine Brunotte  ·  +49-341-97  ·  janine.brunotte@medizin.uni-leipzig.de

Always discuss trial participation with your own doctor first.

Locations (1)

University Clinic LeipzigLeipzig, Saxony, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06112171